Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-08

FDA Approved: NEOSTIGMINE — Supplemental Application (Dr.Reddy's Laboratories Inc)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' supplemental application for neostigmine (generic) under the ANDA program. This action records an approval of a supplemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine (neostigmine)

Snippet

SUPPL AP for NEOSTIGMINE (NEOSTIGMINE)